CompletedNCT00204061
Amisulpride with supportive care for late early-warning signs of psychosis
About this title
Read the official source — NCT00204061Medication studyAges 14–36GermanySchizophrenia
Understand this study
Who was this study for?
Listed age limits: 14 years to 36 years.
- Listed locations
- CologneSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 124
- Sponsor
- University of Cologne
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Germany
- Age range
- From 14 Years to 36 Years
- Official registry ID
- NCT00204061
- Official title
Show the full official title
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cologne
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Cologne, a university.
Did this study involve medication?
Yes. The study involved medication, including Amisulpride.
Who was this study for?
Listed age limits: 14 years to 36 years.
